tradingkey.logo
tradingkey.logo
Search

Intelligent Bio Solutions Completes Clinical Cut-Off Study

ReutersApr 2, 2026 1:49 PM

- Intelligent Bio Solutions Inc INBS.O:

  • INTELLIGENT BIO SOLUTIONS COMPLETES CLINICAL CUT-OFF STUDY, ADVANCES FDA 510(K) CLINICAL PROGRAM TARGETING MULTI-BILLION-DOLLAR U.S. DRUG SCREENING MARKET

  • INTELLIGENT BIO SOLUTIONS INC: NOW INITIATED SECOND PHASE OF ITS CLINICAL STUDY PROGRAM

  • INTELLIGENT BIO SOLUTIONS INC: EXPECTS TO COMPLETE METHOD COMPARISON AND USABILITY STUDY BY END OF JUNE 2026

  • INTELLIGENT BIO SOLUTIONS INC: COMPLETION OF INTERFERENCE STUDY IS ANTICIPATED BY END OF JULY 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI